Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Mercedes Carrasco - Director, Corporate Communications John Butler - CEO, President & Director David Spellman - SVP, CFO & Treasurer Conference Call Participants Allison Bratzel - Piper Sandler & Co. Mara Goldstein - Mizuho Securities Antonio Arce - H.C. Wainwright & Co. Rohit Bhasin - Needham Operator Ladies and gentlemen, thank you for standing by, and welcome to the Akebia First Quarter 20 ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2021 Earnings Conference Call November 9, 2021 9:00 AM ET Company Participants Mercedes Carrasco - Director, Corporate Communications John Butler - Chief Executive Officer Dave Spellman - Chief Financial Officer Dell Faulkingham - Chief Commercial Officer Steven Burke - Head of R&D and Chief Medical Officer Conference Call Participants Alli Bratzel - Piper Sandler Alethia Young - Cantor Fitzgerald Eric Joseph - JP Morgan Serge Belanger - Needham and Company Avatar ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q2 2021 Results Conference Call August 5, 2021 9:00 AM ET Company Participants Kristen Sheppard - SVP, IR John Butler - CEO David Spellman - CFO Dr. Steven Burke - Chief Medical Officer Dell Faulkingham - Chief Commercial Officer Conference Call Participants Ally Bratzel - Piper Sandler Bert Hazlett - BTIG Eric Joseph - JP Morgan Ed Arce - H.C. Wainwright Operator Good day, ladies and gentlemen, and welcome to Akebia Therapeutics Second Quarter of 2021 Financial Resul ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2021 Earnings Conference Call May 10, 2021 9:00 AM ET Company Participants Kristen Sheppard - Senior Vice President, Investor Relations John Butler - Chief Executive Officer David Spellman - Chief Financial Officer Conference Call Participants Ally Bratzel - Piper Sandler Alethia Young - Cantor Fitzgerald Difei Yang - Mizuho Securities Bert Hazlett - BTIG David Lebovitz - Morgan Stanley Ed Arce - H.C. Wainwright Operator Good day, ladies and gentlemen and welcome t ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q4 2020 Earnings Conference Call February 25, 2021 9:00 AM ET Company Participants Kristen Sheppard - VP, IR John Butler - CEO, President & Director David Spellman - SVP, CFO & Treasurer Conference Call Participants Christopher Raymond - Piper Sandler & Co. Difei Yang - Mizuho Securities Antonio Arce - H.C. Wainwright & Co. David Lebowitz - Morgan Stanley Eric Joseph - JPMorgan Chase & Co. Operator Ladies and gentlemen, thank you for standing by, and welcome to Akebia ...